These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14862297)

  • 21. Para-aminosalicylic acid (PAS) in chronic pulmonary tuberculosis.
    DOONEIEF AS; BUCHBERG A; STEINBACH MM
    N Engl J Med; 1950 Jun; 242(22):859-62. PubMed ID: 15416913
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparative study of the effects of para-amino salicylic acid and thephorin on the emergence of streptomycin resistant Salmonella.
    FROMBERG V
    Am J Pharm Sci Support Public Health; 1951 Apr; 123(4):116-22. PubMed ID: 14838103
    [No Abstract]   [Full Text] [Related]  

  • 23. Benemid and carinamide: comparison of effect on para-aminosalicylic acid (PAS) plasma concentrations.
    BOGER WP; PITTS FW; GALLAGHER ME
    J Lab Clin Med; 1950 Aug; 36(2):276-282. PubMed ID: 15437091
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of Para-amino-salicylic Acid on Prothrombin Time.
    Lynch MJ
    J Clin Pathol; 1950 May; 3(2):114-7. PubMed ID: 16810863
    [No Abstract]   [Full Text] [Related]  

  • 25. Streptomycin and para-amino-salicylic acid in the treatment of renal tuberculosis; some clinical experiences.
    ROSCHER F
    Acta Chir Scand; 1952 Dec; 104(2-3):215-23. PubMed ID: 13039830
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy of pulmonary tuberculosis with isoniazid alone and in combination with streptomycin and with para-amino-salicylic acid.
    THOREN M; HINSHAW HC
    Stanford Med Bull; 1952 Nov; 10(4):316-8. PubMed ID: 13015302
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the behavior of the p-amino-salicylic acid and isonicotinic acid hydrazid system in aqueous solutions].
    WILLI AV; FISCHER R
    Med Exp Int J Exp Med; 1960; 3():321-8. PubMed ID: 13785381
    [No Abstract]   [Full Text] [Related]  

  • 28. [Formation of metabolites of benzoyl-para-amino-salicylic acid (C-14-B-PAS) in the rat liver and its excretion in the urine and bile].
    JEUNET F; LAUBER E; AEBI H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962; 242():564-75. PubMed ID: 14451756
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of p-(di-n-propylsulfamyl)-benzoic acid, "benemid", on para-aminosalicylic acid (PAS) plasma concentrations.
    BOGER WP; PITTS FW
    Am Rev Tuberc; 1950 Jun; 61(6):862-7. PubMed ID: 15413771
    [No Abstract]   [Full Text] [Related]  

  • 30. [Research on p-aminobenzoic, p-aminosalicylic, salicylic and gentisic acids].
    MAINARDI L; SEMENZA F
    Boll Soc Ital Biol Sper; 1951 Mar; 27(3 bis):352-4. PubMed ID: 14858665
    [No Abstract]   [Full Text] [Related]  

  • 31. [Investigations of biologic properties of salicylic and para-aminosalicylic acids].
    JIRA J
    Cas Lek Cesk; 1950 Dec; 89(52):1477-82. PubMed ID: 14812478
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of sodium para-amino-salicylate on disorders of keratinization].
    THIERS H
    J Med Lyon; 1950 Aug; 31(735):699-700. PubMed ID: 15437135
    [No Abstract]   [Full Text] [Related]  

  • 33. Antithyroid effect of p-amino-salicylic acid and m-aminophenol.
    KJERULF-JENSEN K; WOLFFBRANDT G
    Acta Pharmacol Toxicol (Copenh); 1951; 7(4):376-80. PubMed ID: 14894251
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of para-amino salicylic acid in the treatment of tuberculosis.
    MARKOE RC
    J Natl Med Assoc; 1950 Nov; 42(6):364-6. PubMed ID: 14795217
    [No Abstract]   [Full Text] [Related]  

  • 35. [Behavior of blood concentration and elimination in the urine of p-aminosalicylic acid after administration of substances with retarding action; experimental and clinical research].
    BERTOLANI F
    Rass Fisiopatol Clin Ter; 1950; 22(1-2):41-62. PubMed ID: 15441150
    [No Abstract]   [Full Text] [Related]  

  • 36. An in vitro study of the synergistic action of aureomycin and para-amino salicylic acid against some pathogenic bacteria.
    SIRSI M; KALE LS
    Indian J Med Res; 1951 Jul; 39(3):397-402. PubMed ID: 14937755
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxic reactions in the use of para amino salicylic acid.
    BROOKE NH; CABLE JV
    N Z Med J; 1952 Dec; 51(286):368-71. PubMed ID: 13037080
    [No Abstract]   [Full Text] [Related]  

  • 38. Para-aminosalicylic acid in experimental tuberculosis in guinea pigs.
    FELDMAN WH; KARLSON AG; HINSHAW HC
    Proc Staff Meet Mayo Clin; 1947 Oct; 22(21):473-9. PubMed ID: 20267461
    [No Abstract]   [Full Text] [Related]  

  • 39. Para-amino-salicylic acid in tuberculosis [Hebrew text].
    ZIFRONI A
    Harefuah; 1950 Jan; 38(2):20-2. PubMed ID: 15405045
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of tuberculosis with p-aminosalicylic acid].
    PARAF J; DESBORDES J; PARAF M; ZIVY P
    Hoja Tisiol; 1950 Jun; 10(2):135-47. PubMed ID: 15436062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.